Paternal Expressed Gene 10 (PEG10) is decreased in early-onset preeclampsia
Tóm tắt
Preeclampsia is a severe complication of pregnancy which is attributed to placental dysfunction. The retrotransposon, Paternal Expressed Gene 10 (PEG10) harbours critical placental functions pertaining to placental trophoblast cells. Limited evidence exists on whether PEG10 is involved in preeclampsia pathogenesis. This study characterised the expression and regulation of PEG10 in placentas from patients with early-onset preeclampsia compared to gestation-matched controls. PEG10 expression was measured in plasma and placentas collected from patients with early-onset preeclampsia (< 34 weeks’) and gestation-matched controls using ELISA (protein) and RT-qPCR (mRNA). First-trimester human trophoblast stem cells (hTSCs) were used for in vitro studies. PEG10 expression was measured during hTSC differentiation and hTSC exposure to hypoxia (1% O2) and inflammatory cytokines (IL-6 and TNFα) using RT-qPCR. Functional studies used PEG10 siRNA to measure the effect of reduced PEG10 on canonical TGF-
$$\beta$$
signalling and proliferation using luciferase and xCELLigence assays, respectively. PEG10 mRNA expression was significantly reduced in placentas from patients with early-onset preeclampsia (< 34 weeks’ gestation) relative to controls (p = 0.04, n = 78 vs n = 18 controls). PEG10 protein expression was also reduced in preeclamptic placentas (p = 0.03, n = 5 vs n = 5 controls, blinded assessment of immunohistochemical staining), but neither PEG10 mRNA nor protein could be detected in maternal circulation. PEG10 was most highly expressed in hTSCs, and its expression was reduced as hTSCs differentiated into syncytiotrophoblasts (p < 0.0001) and extravillous trophoblasts (p < 0.001). Trophoblast differentiation was not altered when hTSCs were treated with PEG10 siRNA (n = 5 vs n = 5 controls). PEG10 was significantly reduced in hTSCs exposed to hypoxia (p < 0.01). PEG10 was also reduced in hTSCs treated with the inflammatory cytokine TNF
$$\alpha$$
(p < 0.01), but not IL-6. PEG10 knocked down (siRNA) in hTSCs showed reduced activation of the canonical TGF-β signalling effector, the SMAD binding element (p < 0.05) relative to controls. PEG10 knockdown in hTSCs however was not associated with any significant alterations in proliferation. Placental PEG10 is reduced in patients with early-onset preeclampsia. In vitro studies suggest that hypoxia and inflammation may contribute to PEG10 downregulation. Reduced PEG10 alters canonical TGF-
$$\beta$$
signalling, and thus may be involved in trophoblast dysfunction associated with this pathway.
Tài liệu tham khảo
Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019;124(7):1094–112.
Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130–7.
Fox R, Kitt J, Leeson P, Aye CYL, Lewandowski AJ. Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring. J Clin Med. 2019;8(10):1625.
Roberts JM, Rich-Edwards JW, McElrath TF, Garmire L, Myatt L, Global Pregnancy Collaboration. Subtypes of preeclampsia: recognition and determining clinical usefulness. Hypertension. 2021;77(5):1430–41.
Albrecht ED, Pepe GJ. Regulation of uterine spiral artery remodeling: a review. Reprod Sci. 2020;27(10):1932–42.
Opichka MA, Rappelt MW, Gutterman DD, Grobe JL, McIntosh JJ. Vascular dysfunction in preeclampsia. Cells. 2021;10(11):3055. https://doi.org/10.3390/cells10113055.
Bell MJ. A historical overview of preeclampsia-eclampsia. J Obstet Gynecol Neonatal Nurs. 2010;39(5):510–8.
Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:l2381.
Imakawa K, Kusama K, Kaneko-Ishino T, Nakagawa S, Kitao K, Miyazawa T, et al. Endogenous retroviruses and placental evolution, development, and diversity. Cells. 2022;11(15):2458. https://doi.org/10.3390/cells11152458.
Kaneko-Ishino T, Ishino F. The Evolution of the Placenta and Viviparity is Related to LTR Retrotransposon-Derived Genes in Mammals. J Mammalian Ova Res. 2013;30(1):16–23 (8).
Chuong EB. The placenta goes viral: retroviruses control gene expression in pregnancy. PLoS Biol. 2018;16(10):e3000028.
Imakawa K, Nakagawa S. Chapter four - the phylogeny of placental evolution through dynamic integrations of retrotransposons. In: Huckle WR, editor. Progress in molecular biology and translational science. Academic Press. 2017;145:89–109.
Youngson NA, Kocialkowski S, Peel N, Ferguson-Smith AC. A small family of sushi-class retrotransposon-derived genes in mammals and their relation to genomic imprinting. J Mol Evol. 2005;61(4):481–90.
Chen H, Sun M, Liu J, Tong C, Meng T. Silencing of Paternally Expressed Gene 10 Inhibits Trophoblast Proliferation and Invasion. PloS one. 2015;10(12):e0144845.
Ono R, Nakamura K, Inoue K, Naruse M, Usami T, Wakisaka-Saito N, et al. Deletion of Peg10, an imprinted gene acquired from a retrotransposon, causes early embryonic lethality. Nat Genet. 2006;38(1):101–6.
Shiura H, Ono R, Tachibana S, Kohda T, Kaneko-Ishino T, Ishino F. PEG10 viral aspartic protease domain is essential for the maintenance of fetal capillary structure in the mouse placenta. Development (Cambridge, England). 2021;148(19):dev199564.
Abed M, Verschueren E, Budayeva H, Liu P, Kirkpatrick DS, Reja R, et al. The Gag protein PEG10 binds to RNA and regulates trophoblast stem cell lineage specification. PLoS ONE. 2019;14(4):e0214110.
Xie T, Pan S, Zheng H, Luo Z, Tembo KM, Jamal M, et al. PEG10 as an oncogene: expression regulatory mechanisms and role in tumor progression. Cancer Cell Int. 2018;18(1):112.
Tsou AP, Chuang YC, Su JY, Yang CW, Liao YL, Liu WK, et al. Overexpression of a novel imprinted gene, PEG10, in human hepatocellular carcinoma and in regenerating mouse livers. J Biomed Sci. 2003;10(6 Pt 1):625–35.
Bang H, Ha SY, Hwang SH, Park C-K. Expression of PEG10 is associated with poor survival and tumor recurrence in hepatocellular carcinoma. Cancer Res Treat. 2015;47(4):844–52.
Li CM, Margolin AA, Salas M, Memeo L, Mansukhani M, Hibshoosh H, et al. PEG10 is a c-MYC target gene in cancer cells. Cancer Res. 2006;66(2):665–72.
Li X, Xiao R, Tembo K, Hao L, Xiong M, Pan S, et al. PEG10 promotes human breast cancer cell proliferation, migration and invasion. Int J Oncol. 2016;48(5):1933–42.
Peng YP, Zhu Y, Yin LD, Zhang JJ, Wei JS, Liu X, et al. PEG10 overexpression induced by E2F–1 promotes cell proliferation, migration, and invasion in pancreatic cancer. J Exp Clin Cancer Res. 2017;36(1):30.
Watson KM, Gardner IH, Byrne RM, Ruhl RR, Lanciault CP, Dewey EN, et al. Differential expression of PEG10 contributes to aggressive disease in early versus late-onset colorectal cancer. Dis Colon Rectum. 2020;63(12):1610–20.
Akamatsu S, Wyatt Alexander W, Lin D, Lysakowski S, Zhang F, Kim S, et al. the placental gene PEG10 promotes progression of neuroendocrine prostate cancer. Cell Rep. 2015;12(6):922–36.
Wu MY, Hill CS. Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev Cell. 2009;16(3):329–43.
Chen H, Sun M, Zhao G, Liu J, Gao W, Si S, et al. Elevated expression of PEG10 in human placentas from preeclamptic pregnancies. Acta Histochem. 2012;114(6):589–93.
Liang XY, Chen X, Jin YZ, Chen XO, Chen QZ. Expression and significance of the imprinted gene PEG10 in placenta of patients with preeclampsia. Genet Mol Res. 2014;13(4):10607–14.
Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstetrics & Gynecology. 2020;135(6).
Okae H, Toh H, Sato T, Hiura H, Takahashi S, Shirane K, et al. Derivation of human trophoblast stem cells. Cell Stem Cell. 2018;22(1):50–63.e6.
Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B, et al. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell. 1998;1(4):611–7.
Kaitu’u-Lino TJ, Tong S, Beard S, Hastie R, Tuohey L, Brownfoot F, et al. Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglin. Pregnancy Hypertens. 2014;4(4):287–95.
Hutter D, Kingdom J, Jaeggi E. Causes and mechanisms of intrauterine hypoxia and its impact on the fetal cardiovascular system: a review. Int J Pediatr. 2010;2010:401323.
Harmon AC, Cornelius DC, Amaral LM, Faulkner JL, Cunningham MW Jr, Wallace K, et al. The role of inflammation in the pathology of preeclampsia. Clin Sci (Lond). 2016;130(6):409–19.
Wójtowicz A, Zembala-Szczerba M, Babczyk D, Kołodziejczyk-Pietruszka M, Lewaczyńska O, Huras H. Early- and Late-Onset preeclampsia: a comprehensive cohort study of laboratory and clinical findings according to the new ISHHP criteria. Int J Hypertens. 2019;2019:4108271.
Redman CW. Early and late onset preeclampsia: Two sides of the same coin. Pregnancy Hypertens: Int J Womens Cardiovasc Health. 2017;7:58.
Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia. Hypertension. 2008;52(5):873–80.
Ren Z, Gao Y, Gao Y, Liang G, Chen Q, Jiang S, et al. Distinct placental molecular processes associated with early-onset and late-onset preeclampsia. Theranostics. 2021;11(10):5028–44.
Guo F, Zhang B, Yang H, Fu Y, Wang Y, Huang J, et al. Systemic transcriptome comparison between early- And late-onset pre-eclampsia shows distinct pathology and novel biomarkers. Cell Prolif. 2021;54(2):e12968.
Smallwood A, Papageorghiou A, Nicolaides K, Alley MKR, Jim A, Nargund G, et al. Temporal regulation of the expression of syncytin (HERV-W), maternally imprinted PEG10, and SGCE in human placenta1. Biol Reprod. 2003;69(1):286–93.
Huppertz B, Weiss G, Moser G. Trophoblast invasion and oxygenation of the placenta: measurements versus presumptions. J Reprod Immunol. 2014;101–102:74–9.
Burton GJ, Cindrova-Davies T, Yung Hw, Jauniaux E. Hypoxia and reproductive health: oxygen and development of the human placenta. Reproduction. 2021;161(1):F53–65.
Genbacev O, Joslin R, Damsky CH, Polliotti BM, Fisher SJ. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest. 1996;97(2):540–50.
Liu Z-w, Zhang Y-m, Zhang L-y, Zhou T, Li Y-y, Zhou G-c, et al. Duality of interactions between TGF-β and TNF-α During Tumor Formation. Frontiers in Immunology. 2022;12:810286. https://doi.org/10.3389/fimmu.2021.810286.
Shinohara N, Maeda S, Yahiro Y, Sakuma D, Matsuyama K, Imamura K, et al. TGF-β signalling and PEG10 are mutually exclusive and inhibitory in chondrosarcoma cells. Sci Rep. 2017;7(1):13494.
Helmig S, Stephan P, Döhrel J, Schneider J. TNF-α mRNA expression correlates with TGF-β mRNA expression in vivo. Inflammation. 2011;34(4):255–9.
Pekary AE, Berg L, Wang J, Lee P, Dubinett SM, Hershman JM. TNF-alpha, TSH, and aging regulate TGF-beta synthesis and secretion in FRTL-5 rat thyroid cells. Am J Physiol. 1995;268(3 Pt 2):R808–15.
Shin HA, Park M, Banga JP, Lew H. TGFβ-Treated placenta-derived mesenchymal stem cells selectively promote anti-adipogenesis in thyroid-associated ophthalmopathy. Int J Mol Sci. 2022;23(10):5603. https://doi.org/10.3390/ijms23105603.
Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol Aspects Med. 2007;28(2):192–209.
Liu Y, Fan X, Wang R, Lu X, Dang Y-L, Wang H, et al. Single-cell RNA-seq reveals the diversity of trophoblast subtypes and patterns of differentiation in the human placenta. Cell Res. 2018;28(8):819–32.
Chuva de Sousa Lopes SM, Alexdottir MS, Valdimarsdottir G. The TGFβ Family in human placental development at the fetal-maternal interface. Biomolecules. 2020;10(3):453. https://doi.org/10.3390/biom10030453.
Zhao H, Gao Y, Miao J, Chen S, Li J, Li Z, et al. Single-cell RNA-seq highlights a specific carcinoembryonic cluster in ovarian cancer. Cell Death Disease. 2021;12(11):1082.
Zhang M, Sui C, Dai B, Shen W, Lu J, Yang J. PEG10 is imperative for TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Oncol Rep. 2017;37(1):510–8.
Lux A, Beil C, Majety M, Barron S, Gallione CJ, Kuhn HM, et al. Human retroviral gag- and gag-pol-like proteins interact with the transforming growth factor-beta receptor activin receptor-like kinase 1. J Biol Chem. 2005;280(9):8482–93.
Graham CH, Lysiak JJ, McCrae KR, Lala PK. Localization of transforming growth factor-β at the human fetal-maternal interface: role in trophoblast growth and differentiation1. Biol Reprod. 1992;46(4):561–72.